ATE302001T1 - Stabilisierte askorbinsäurederivate - Google Patents
Stabilisierte askorbinsäurederivateInfo
- Publication number
- ATE302001T1 ATE302001T1 AT03717570T AT03717570T ATE302001T1 AT E302001 T1 ATE302001 T1 AT E302001T1 AT 03717570 T AT03717570 T AT 03717570T AT 03717570 T AT03717570 T AT 03717570T AT E302001 T1 ATE302001 T1 AT E302001T1
- Authority
- AT
- Austria
- Prior art keywords
- ascorbic acid
- acid derivatives
- stabilized ascorbic
- carbon atoms
- stabilized
- Prior art date
Links
- 150000000996 L-ascorbic acids Chemical class 0.000 title 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000003289 ascorbyl group Chemical class [H]O[C@@]([H])(C([H])([H])O*)[C@@]1([H])OC(=O)C(O*)=C1O* 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000006239 protecting group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
- C07F9/65515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Birds (AREA)
- Molecular Biology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Hematology (AREA)
- Toxicology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Nutrition Science (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Anti-Oxidant Or Stabilizer Compositions (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002110341 | 2002-04-12 | ||
| US37360902P | 2002-04-19 | 2002-04-19 | |
| PCT/JP2003/004659 WO2003086384A1 (en) | 2002-04-12 | 2003-04-11 | Stabilized ascorbic acid derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE302001T1 true ATE302001T1 (de) | 2005-09-15 |
Family
ID=29253536
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03717570T ATE302001T1 (de) | 2002-04-12 | 2003-04-11 | Stabilisierte askorbinsäurederivate |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US7223775B2 (de) |
| EP (1) | EP1496889B1 (de) |
| JP (1) | JP4111856B2 (de) |
| CN (1) | CN1297266C (de) |
| AT (1) | ATE302001T1 (de) |
| AU (1) | AU2003222450A1 (de) |
| CA (1) | CA2481591C (de) |
| DE (1) | DE60301345T2 (de) |
| ES (1) | ES2243901T3 (de) |
| WO (1) | WO2003086384A1 (de) |
Families Citing this family (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2317067T3 (es) | 2003-10-14 | 2009-04-16 | Showa Denko K.K. | Agente para uso externo cutaneo que contiene una sal de un derivado de acido ascorbico, procedimiento para estabilizar el agente para uso externo cutaneo. |
| EP1666484B1 (de) | 2004-03-25 | 2012-10-31 | Toyo Beauty Co., Ltd. | Ascorbinsäurederivate und kosmetika zur hautbleichung |
| TW200534875A (en) * | 2004-04-23 | 2005-11-01 | Lonza Ag | Personal care compositions and concentrates for making the same |
| KR20070004999A (ko) * | 2004-04-26 | 2007-01-09 | 쇼와 덴코 가부시키가이샤 | 토코페롤 유도체, 아스코르브산 유도체 및 리포펩티드구조를 갖는 계면활성제를 함유하는 피부 외용제 |
| JP4786419B2 (ja) * | 2006-05-30 | 2011-10-05 | 日本メナード化粧品株式会社 | アスコルビン酸−２−リン酸エステル誘導体を含有する組成物 |
| JP5342102B2 (ja) | 2006-07-04 | 2013-11-13 | 昭和電工株式会社 | エマルション組成物 |
| DE102006037724A1 (de) * | 2006-08-11 | 2008-02-14 | Merck Patent Gmbh | Verwendung von Ascorbinsäurederivaten zur Funktionalisierung von Matrices |
| US20130115320A1 (en) | 2007-03-30 | 2013-05-09 | Dynova Laboratories, Inc. | Therapeutic agent for intranasal administration and method of making and using same |
| US8211477B2 (en) * | 2007-10-17 | 2012-07-03 | Biova, L.L.C. | Solubilized protein composition obtained from eggshell membrane |
| US7749284B2 (en) * | 2008-04-28 | 2010-07-06 | Aveda Corporation | Oxidative hair dye compositions, methods and products |
| EP2316449B1 (de) * | 2008-08-06 | 2013-10-02 | Daiichi Sankyo Healthcare Co., Ltd. | Stabile pharmazeutische zusammensetzung mit tranexamsäure und ascorbinsäure |
| GB2470040A (en) * | 2009-05-06 | 2010-11-10 | Systagenix Wound Man Ip Co Bv | Wound dressing material comprising N-acetyl cysteine |
| JP5552386B2 (ja) * | 2010-07-09 | 2014-07-16 | 株式会社ファンケル | Ｌ−アスコルビン酸−２−リン酸−６−脂肪酸凍結乾燥製剤及び化粧料 |
| US8435541B2 (en) | 2010-09-02 | 2013-05-07 | Bath & Body Works Brand Management, Inc. | Topical compositions for inhibiting matrix metalloproteases and providing antioxidative activities |
| US20130022687A1 (en) * | 2011-07-19 | 2013-01-24 | Fitzgerald Jr John James | Topical transdermal method for delivering nutrients through the skin for expedited wound healing |
| FR2978963A1 (fr) | 2011-08-11 | 2013-02-15 | Ascorbix | Nouveaux derives des furanones et composition pharmaceutique les contenant |
| DE21212055T1 (de) | 2011-12-07 | 2022-08-04 | Alnylam Pharmaceuticals, Inc. | Biologisch abbaubare lipide zur freisetzung von wirkstoffen |
| JP6001902B2 (ja) * | 2012-03-30 | 2016-10-05 | 株式会社コーセー | アスコルビン酸誘導体が配合された組成物 |
| JP6010317B2 (ja) * | 2012-03-30 | 2016-10-19 | 株式会社コーセー | アスコルビン酸誘導体が配合された水中油型乳化組成物 |
| EP2813208B1 (de) * | 2012-12-20 | 2017-09-27 | Showa Denko K.K. | Ascorbinsäurederivatzusammensetzung und herstellungsverfahren dafür, ascorbinsäurederivatlösung sowie hautpräparat zur äusseren anwendung |
| WO2014174583A1 (ja) * | 2013-04-23 | 2014-10-30 | 株式会社ニチレイバイオサイエンス | 新規美白剤 |
| CN105792810A (zh) | 2013-07-25 | 2016-07-20 | 绮丽儿·李·艾柏汀 | 用于表皮修复的配方 |
| CN103445018B (zh) * | 2013-08-22 | 2014-11-12 | 福建天马科技集团股份有限公司 | 虹鳟稚鱼浮性膨化颗粒配合饲料 |
| CN103554070A (zh) * | 2013-11-08 | 2014-02-05 | 李玉成 | 抗坏血酸氧铋、其制备方法及应用 |
| CA2953341C (en) | 2014-06-25 | 2023-01-24 | Acuitas Therapeutics Inc. | Lipids and lipid nanoparticle formulations for delivery of nucleic acids |
| WO2016176330A1 (en) | 2015-04-27 | 2016-11-03 | The Trustees Of The University Of Pennsylvania | Nucleoside-modified rna for inducing an adaptive immune response |
| HUE067372T2 (hu) | 2015-06-29 | 2024-10-28 | Acuitas Therapeutics Inc | Lipidek és nanoszemcsés lipid formulázások nukleinsavak beadására |
| CN108368028B (zh) | 2015-10-28 | 2021-09-03 | 爱康泰生治疗公司 | 用于递送核酸的新型脂质和脂质纳米颗粒制剂 |
| US12678515B2 (en) | 2015-12-30 | 2026-07-14 | Acuitas Therapeutics, Inc. | Lipids and lipid nanoparticle formulations for delivery of nucleic acids |
| US12491261B2 (en) | 2016-10-26 | 2025-12-09 | Acuitas Therapeutics, Inc. | Lipid nanoparticle formulations |
| EP3568155A4 (de) | 2017-01-11 | 2020-09-23 | The Trustees Of The University Of Pennsylvania | Nukleosid-modifizierte rna zur induktion einer immunreaktion gegen zika-virus |
| US11357856B2 (en) | 2017-04-13 | 2022-06-14 | Acuitas Therapeutics, Inc. | Lipids for delivery of active agents |
| US11820728B2 (en) | 2017-04-28 | 2023-11-21 | Acuitas Therapeutics, Inc. | Carbonyl lipids and lipid nanoparticle formulations for delivery of nucleic acids |
| JP7355731B2 (ja) | 2017-08-16 | 2023-10-03 | アクイタス セラピューティクス インコーポレイテッド | 脂質ナノ粒子製剤における使用のための脂質 |
| US11524932B2 (en) | 2017-08-17 | 2022-12-13 | Acuitas Therapeutics, Inc. | Lipids for use in lipid nanoparticle formulations |
| WO2019036028A1 (en) | 2017-08-17 | 2019-02-21 | Acuitas Therapeutics, Inc. | LIPIDS FOR USE IN LIPID NANOPARTICULAR FORMULATIONS |
| JP7461872B2 (ja) | 2017-08-17 | 2024-04-04 | アクイタス セラピューティクス インコーポレイテッド | 脂質ナノ粒子製剤における使用のための脂質 |
| WO2019236866A1 (en) * | 2018-06-07 | 2019-12-12 | Powdermet, Inc. | Non-linear surfactant |
| EP3852911B1 (de) | 2018-09-21 | 2025-01-22 | Acuitas Therapeutics, Inc. | Systeme und verfahren zur herstellung von lipidnanopartikeln und liposomen |
| CA3116576A1 (en) | 2018-10-18 | 2020-04-23 | Acuitas Therapeutics, Inc. | Lipids for lipid nanoparticle delivery of active agents |
| PL3908568T3 (pl) | 2019-01-11 | 2024-12-02 | Acuitas Therapeutics, Inc. | Lipidy do dostarczania środków czynnych w nanocząstkach lipidowych |
| CA3178344A1 (en) | 2020-03-31 | 2021-10-07 | The Trustees Of The University Of Pennsylvania | Universal influenza vaccine using nucleoside-modified mrna |
| EP4178544A4 (de) | 2020-07-08 | 2024-09-25 | The Trustees of the University of Pennsylvania | Nukleosidmodifizierte rna zur induktion einer immunreaktion gegen sars-cov-2 |
| KR20230051172A (ko) | 2020-07-16 | 2023-04-17 | 아퀴타스 테라퓨틱스 인크. | 지질 나노 입자에 사용하기 위한 양이온성 지질 |
| JPWO2022059763A1 (de) * | 2020-09-17 | 2022-03-24 | ||
| JP7276887B2 (ja) * | 2020-11-30 | 2023-05-18 | 東洋ビューティ株式会社 | Ｉｉｉ型コラーゲン産生促進剤および抗老化化粧料 |
| JP2024518639A (ja) | 2021-05-20 | 2024-05-01 | ロック オプコ リミテッド ライアビリティ カンパニー | ビタミンｃ化合物を含有する化粧品組成物及びその使用 |
| WO2023114943A2 (en) | 2021-12-16 | 2023-06-22 | Acuitas Therapeutics, Inc. | Lipids for use in lipid nanoparticle formulations |
| CN115154349A (zh) * | 2022-07-19 | 2022-10-11 | 何直源 | 一种基于硫代二丙酸和抗坏血酸的美白组合物 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5218191B1 (de) | 1967-10-31 | 1977-05-20 | ||
| JPS58222076A (ja) | 1982-06-17 | 1983-12-23 | Toyama Chem Co Ltd | ２−アミノチアゾ−ル誘導体 |
| JPS58222078A (ja) | 1982-06-17 | 1983-12-23 | Santen Pharmaceut Co Ltd | アスコルビン酸誘導体 |
| JPS6150908A (ja) | 1984-08-20 | 1986-03-13 | Kanebo Ltd | 皮膚化粧料 |
| JPS61152613A (ja) * | 1984-12-26 | 1986-07-11 | Kanebo Ltd | 皮膚化粧料 |
| US4939128A (en) * | 1988-04-25 | 1990-07-03 | Takeda Chemical Industries, Ltd. | Ester of ascorbic acid 2-phosphate and pharmaceutical use |
| EP0875246A1 (de) * | 1997-04-04 | 1998-11-04 | Showa Denko Kabushiki Kaisha | Pharmazeutische Zusammensetzung aus Ascorbinsäurederivate zur Behandlung von Krebs |
| FR2762607B1 (fr) | 1997-04-29 | 1999-06-11 | Atochem Elf Sa | Systeme monocomposant a base de latex coreactifs conduisant a des revetements reticulables a temperature ambiante et post-reticulables par traitement et leur application dans le domaine des revetements |
| JPH10298174A (ja) * | 1997-04-30 | 1998-11-10 | Showa Denko Kk | アスコルビン酸誘導体及びそれを含有するビタミンｃ剤 |
| DE19936686A1 (de) | 1999-08-04 | 2001-02-08 | Beiersdorf Ag | Verwendung von kosmetischen oder dermatologischen Zubereitungen zur Stabilisierung von Ascorbinsäure und/oder Ascorbylverbindungen |
| AU2001236001A1 (en) | 2000-02-29 | 2001-09-12 | Showa Denko K.K. | Immune enhancement compositions and use thereof |
-
2003
- 2003-03-31 JP JP2003096750A patent/JP4111856B2/ja not_active Expired - Lifetime
- 2003-04-11 WO PCT/JP2003/004659 patent/WO2003086384A1/en not_active Ceased
- 2003-04-11 ES ES03717570T patent/ES2243901T3/es not_active Expired - Lifetime
- 2003-04-11 CA CA002481591A patent/CA2481591C/en not_active Expired - Fee Related
- 2003-04-11 AU AU2003222450A patent/AU2003222450A1/en not_active Abandoned
- 2003-04-11 AT AT03717570T patent/ATE302001T1/de not_active IP Right Cessation
- 2003-04-11 US US10/510,756 patent/US7223775B2/en not_active Expired - Fee Related
- 2003-04-11 EP EP03717570A patent/EP1496889B1/de not_active Expired - Lifetime
- 2003-04-11 CN CNB038134462A patent/CN1297266C/zh not_active Expired - Fee Related
- 2003-04-11 DE DE60301345T patent/DE60301345T2/de not_active Expired - Lifetime
-
2007
- 2007-02-08 US US11/672,677 patent/US7507750B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DE60301345D1 (de) | 2005-09-22 |
| ES2243901T3 (es) | 2005-12-01 |
| CA2481591A1 (en) | 2003-10-23 |
| US7223775B2 (en) | 2007-05-29 |
| CN1297266C (zh) | 2007-01-31 |
| US20070141000A1 (en) | 2007-06-21 |
| DE60301345T2 (de) | 2006-06-29 |
| WO2003086384A1 (en) | 2003-10-23 |
| CN1658864A (zh) | 2005-08-24 |
| EP1496889B1 (de) | 2005-08-17 |
| JP2004002359A (ja) | 2004-01-08 |
| JP4111856B2 (ja) | 2008-07-02 |
| US20060100177A1 (en) | 2006-05-11 |
| EP1496889A1 (de) | 2005-01-19 |
| US7507750B2 (en) | 2009-03-24 |
| CA2481591C (en) | 2009-08-18 |
| AU2003222450A1 (en) | 2003-10-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60301345D1 (de) | Stabilisierte askorbinsäurederivate | |
| MX2010013275A (es) | Compuesto novedoso de uracilo o su sal que tiene actividad inhibidora de desoxiuridin trifosfatasa de humano. | |
| TW200606137A (en) | Urea derivatives | |
| TWI265929B (en) | Triazinyl derivatives for inhibiting the production of IL-12 | |
| EP1634874A4 (de) | Imidazolidinderivate | |
| ATE125539T1 (de) | 1,4-benzothiazedinderivat. | |
| MX2010001344A (es) | Compuesto de acido fenilacetico. | |
| EA200200098A1 (ru) | Ароматические сложные эфиры для маркировки или мечения нефтепродуктов | |
| DE69929669D1 (de) | Zyklische Amidderivate die Cathepsin K hemmen | |
| UA89672C2 (en) | Sulfonylamino(thio)carbonyl compounds | |
| WO2004080408A3 (en) | Method of treating cancer with azaspirane compositions | |
| ATE233264T1 (de) | Polynalbuphinderivat | |
| DK1663122T3 (da) | Mundskyllesammensætninger indeholdende N-acyl-argininalkylestersalte | |
| ATE320417T1 (de) | Naphthimidobenzamid-derivate | |
| WO2008102546A1 (ja) | チエタン化合物、これを含む重合性組成物およびその使用 | |
| ES2120498T3 (es) | Nuevo compuesto tetraciclico. | |
| RU1804462C (en) | Method of cefem compounds or theirs salts synthesis | |
| TWI349547B (en) | Ptx3 gene expression suppressing method | |
| EP1403250A4 (de) | Bis(5-aryl-2-pyridyl)derivate | |
| WO2009063782A1 (ja) | 皮膚外用組成物 | |
| EA200500716A1 (ru) | Новые соединения 2,3-дигидро-4-(1h)-пиридона, способ их получения и фармацевтические композиции, которые их содержат | |
| TW200504057A (en) | Benzothiophene derivative | |
| EP1484319A4 (de) | Kettenförmiger oligomilchsäurethioester | |
| WO2003033494A1 (en) | Benzimidazole derivative | |
| MXPA05008190A (es) | Derivado de oligosacarido. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |